Denis Hadjiliadis, MD, MHS , PhD
Paul F. Harron, Jr. Associate Professor
Director, Adult Cystic Fibrosis Program, University of Pennsylvania
Director, Advanced Lung Disease Research Group, University of Pennsylvania
(Chemical Engineering (B.Eng; 2 years completed))
Faculty of Engineering, McGill University, Montreal, Canada, 1991.
(Doctor of Medicine Program)
Faculty of Medicine, University of Toronto, Canada, 1995.
(Master’s of Health Sciences Program)
Duke University Medical Center, Durham, NC, 2001.
(Ph.D in Medicine Program)
University of Ioannina, Ioannina, Greece, 2005.
Resident, Internal Medicine, Mayo Graduate School of Medicine, Rochester, MN, 1995-1998.
Fellow, Pulmonary and Critical Care Medicine, Duke University Medical Center, Durham, NC, 1998-2001.
Fellow, Lung Transplantation and Cystic Fibrosis, University of Toronto, Toronto, Ontario, Canada, 2001-2002.
Leading Success Program, University of Pennsylvania, 2012-2013.
Diplomate, American Board of Internal Medicine, Internal Medicine (Recertified in Oct. 2008), 1998.
Royal College of Physicians of Canada, Internal Medicine, November 1999, 1999.
Diplomate, American Board of Internal Medicine, Pulmonary Disease (Recertified in April 2010), 2000.
Diplomate, American Board of Internal Medicine, Critical Care Medicine (Recertified in November 2011), 2001.
Royal College of Physicians of Canada, Respiratory Medicine, September 2002, 2002.
Pneumonology, Greek Ministry of Health, December 2004, 2004.
End-stage Lung Disease
Dr Hadjiliadis oversees one of the largest adult cystic fibrosis clinics in North America. He also has experience in the diagnosis and management of patients with bronchiectasis and CFTR-related disorder. In addition, he is a member of the Penn Lung Transplantation team and takes care of patients with end-stage lung disease requiring transplant.
Multiple clinical trials in the above areas are available to patients at the University of Pennsylvania
back to top
Last updated: 09/19/2016
The Trustees of the University of Pennsylvania